ClinicalTrials.gg
CompletedNCT07203560Updated Oct 2, 2025

Effect of Neurodynamic Mobilization in Patients With Lumbar Disc Herniation

An interventional study of Neurodynamic Mobilization and Conventional Physiotherapy in Lumbar Disc Herniation and Low Back Pain, sponsored by Aydin Adnan Menderes University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-10-02.

Sponsored by Aydin Adnan Menderes University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 3 months after the study started (first participant enrolled Jun 2018, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The objective of this randomized controlled trial was to investigate the effects of neurodynamic mobilization on pain intensity, normal joint motion, neurodynamics, functional level, and disability in patients with lumbar disc herniation.

Read the detailed description

Background: Low back pain is a major cause of disability worldwide, and due to the limited effectiveness of current treatments, this study aimed to evaluate the efficacy of neurodynamic mobilization technique on pain intensity, range of motion, neurodynamics, functional status, and disability in patients.

Methods: Thirty-seven patients were randomized to control or mobilization group. Participants in the control group received a conventional therapy for 20 treatment sessions, and those in the mobilization group were treated neurodynamic mobilization in addition to the electro/thermal therapy program twice a week for 4 consecutive weeks. Pain level at rest and during activity was recorded with a Visual Analog Scale. Active lumbar flexion, extension, and lateral flexion were measured with a universal goniometer. Neurodynamic mobility was evaluated using neurodynamic tests. The functional status was assessed with the 30-second chair stand test and disability was evaluated with the Bournemouth Questionnaire. 2x2 repeated measures ANOVA models were used to determine within and between group differences.

02

Conditions studied

  • Lumbar Disc Herniation
  • Low Back Pain

Keywords

  • low back pain
  • sciatica
  • Disability Evaluation
  • Musculoskeletal Manipulations
03

In context

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 100 are open to participants now.

This study's enrollment of 40 is below the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Aydin Adnan Menderes University is the lead sponsor of 241 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 20 and 60 years
  • Diagnosed with lumbar disc herniation at one or more of the L3-L4, L4-L5
  • L5-S1 levels with prolapsed, protruding, or extruding disc confirmed by MRI
  • Presence of low back pain for at least 6 weeks.

Exclusion criteria

Exclusion Criteria:

  • Spinal stenosis
  • Previous lumbar surgery or medical treatment for disc herniation
  • Pregnancy
  • Severe osteoporosis
  • Diabetes mellitus
  • Severe neurological deficit
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Neurodynamic Mobilization + Conventional Therapy (Experimental Group)

    Participants received the conventional physiotherapy program plus neurodynamic mobilization administered by a physical therapist. Treatment was given 5 days a week for 4 weeks, for a total of 20 sessions.

    Other: Neurodynamic Mobilization · Other: Conventional Physiotherapy

  • Active comparator
    Conventional Therapy (Control Group)

    Individuals in control group received hot therapy (Hotpack, 20 minutes), Conventional Tens (60 Hz, 60 msec, 20 minutes) and Therapeutic Ultrasound (1.5 w/cm2, 10 minutes). Patients were given an exercise program to do at home and the treatment was given 5 days a week for 4 weeks, for a total of 20 sessions, to all patients in the study.

    Other: Conventional Physiotherapy

Interventions

  • OtherNeurodynamic Mobilization

    In the experimental group, neurodynamic mobilization was applied in addition to the conventional physiotherapy program. For the neurodynamic mobilization tibial nerve neural mobilization was performed. For neural mobilization of the tibial nerve, the patient was placed in the side-lying position with the hip in 90° flexion, knee flexion and ankle dorsi flexion. In this position, the ankle and hip positions were maintained, and knee extension was performed. When the symptoms were at a level that would not disturb the patient, it was held for 5 seconds, and knee flexion was performed by plantar flexion of the ankle. This practice was performed twice a week with 10 repetitions by a physiotherapist. The same neurodynamic mobilization exercise was recommended to the patients in the neuromobilization group as a home program with 10 repetitions twice a day.

  • OtherConventional Physiotherapy

    All participants received hot pack therapy (20 minutes), conventional TENS (60 Hz, 60 msec, 20 minutes), therapeutic ultrasound (1.5 W/cm², 10 minutes), and a prescribed home exercise program, delivered 5 days per week for 4 weeks (20 sessions in total).

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Patients' rest and activity pain levels was assessed via a visual analog scale (VAS). Participants were asked to mark the intensity of pain they felt on a 10-centimeter (cm) horizontal line (0 indicates no pain, 10 indicates intolerable pain). The point marked on the line was measured with a ruler and the VAS value was recorded in cm

    Time frame: Pain was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment)

Secondary outcomes

  1. ROM

    Rom of the lumbar region was evaluated using a universal goniometer. Lumbar flexion and extension, right and left lateral trunk flexion were measured actively and recorded in terms of degree.

    Time frame: Rom was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).

  2. Neurodynamic Mobility - Slump Test

    Slump test The patient was asked to sit on the edge of the examination table with the knee flexed at 90° and to flex the neck, back, and lower back respectively. He was then asked to bring his big toe towards his head by extending the knee. In this position, the angle between the starting position and the fibula was measured with a universal goniometer. The test was repeated twice and the mean degree was recorded.

    Time frame: These were assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).

  3. Neurodynamic Mobility - Sit and Reach Test

    Sit and Reach test The top of a table with a height of 32 cm and a length of 35 cm was scaled by dividing it into cm. The patient was asked to sit on the floor and rest the sole of her bare foot flat on the test table. She was then instructed to reach as far as possible forward on the table without bending her knees from her trunk. The extreme point at which her fingers extended was measured in cm. In this way, at the farthest point, they waited 1-2 seconds without stretching forward or backward. The test was repeated twice, and the mean was recorded in cm

    Time frame: Baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment)

07

Study locations

1 site
  • Gazi University Department of Physical Therapy and Rehabilitation
    Ankara, Çankaya 06690, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07203560
Responsible party
Gurkan Gunaydin (Associate Professor, Aydin Adnan Menderes University) — Principal investigator
First posted
Oct 2, 2025
Start date
Jun 4, 2018
Primary completion
May 10, 2019
Completion
May 10, 2019
Last update
Oct 2, 2025

Study contacts

Gurkan Gunaydin
principal investigator · Aydin Adnan Menderes University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion